Dose Response. 2021 Mar 30;19(1):15593258211001259. doi: 10.1177/15593258211001259. eCollection 2021 Jan-Mar.
3
Effect of meloxicam (cyclooygenase-2 inhibitor) versus vitamin D3 (cholecalciferol) as ameliorating agents of progressive doxorubicin-induced nephrotoxicity in rats.